Connect with us

Business

Maruti Suzuki targets mini-car surge: Alto and S-Presso prices cut 11-13%; 2-wheeler buyers lured by festive finance – The Times of India

Published

on

Maruti Suzuki targets mini-car surge: Alto and S-Presso prices cut 11-13%; 2-wheeler buyers lured by festive finance – The Times of India


Maruti Suzuki India is intensifying efforts to boost sales of its entry-level cars, aiming to achieve record volumes for the Alto and S-Presso in the ongoing fiscal 2026. The company is relying on aggressive price reductions, festive finance schemes, and a focused push to attract two-wheeler riders into the four-wheeler segment.According to sources familiar with the matter told ET, Maruti has set a target to sell between 220,000 and 250,000 mini cars this fiscal year. The previous record for the segment was around 247,000 units in FY20.The renewed focus on small cars is part of Maruti’s broader strategy to arrest declining market share, which has been under pressure due to a slump in small-car sales alongside rising SUV demand. In FY25, the overall passenger vehicle market grew only 2% in cumulative wholesale dispatches, while Maruti’s market share fell to 40.9%, the lowest since FY13 when it stood at 39%. The company had commanded over 51% market share in FY19 and FY20.Maruti’s optimism is reinforced by a GST rate cut on small cars, which has effectively lowered prices by 11-13%. The company has also introduced a festive Rs 1,999 EMI scheme for entry-level models, launched during Navratri and extending through Diwali, to appeal to two-wheeler owners.

-

Dealers reported a surge in showroom footfalls and enquiries, particularly from rural and small-town buyers, though actual conversions remain limited. “The offer is very attractive and has brought new buyers into showrooms. We expect a major pickup during Dhanteras and Diwali,” said a Maruti dealer in western India.Partho Banerjee, Senior Executive Officer (Sales and Marketing) at Maruti Suzuki, said the entry-level segment is showing early signs of revival. “The response to the Rs 1,999 EMI offer has been very positive. Many two-wheeler customers who earlier did not consider buying a car are now visiting our showrooms. We are literally seeing helmets on discussion tables – that’s a very good indicator,” he told ET.Banerjee added that overall festive-period booking momentum has been strong. “Just to give you a perspective, the Alto bookings in October (till date) were up around 60% compared to the same month last year.” He noted that bookings for cars in the 18% GST bracket, including small cars, have risen sharply, though it is still early to quantify their full impact on overall sales.Industry observers, however, expressed caution over Maruti’s ambitious targets. “It’s a very tall target. Over the last five years, the car buyer has become a lot more aspirational. Even a first-time buyer is not keen on an entry-level model and prefers a second-hand premium hatchback like a Baleno,” said an industry executive, requesting anonymity.Analysts believe that while the push on affordability may come at the cost of average selling price and near-term margins – potentially around 100 basis points – it could expand market share and improve operating leverage if consumer response remains positive. Kapil Singh of Nomura Research noted that the initiative may strengthen Maruti’s base.According to Puneet Gupta, Director, S&P Global Mobility, the GST reduction could reignite demand in the mini-car segment. “Expect a wave of innovation in financing, product offerings, and ownership schemes aimed at reviving this category,” he said. With only 36 cars per 1,000 people, India’s vehicle ownership remains among the lowest globally, and this push could serve as a catalyst for two-wheeler users to transition to four-wheelers.Maruti has reduced prices across its lineup by 2-21%, with the steepest cuts on the Alto, S-Presso, and Celerio (13-22%). Larger models, including the Brezza, Grand Vitara, and Invicto, have seen reductions of 2-8%.Banerjee emphasised that Maruti is committed to maintaining a balanced presence across all segments. “As a market leader, we must have a play across all segments – hatchbacks, SUVs, MPVs, CNG, hybrids, and EVs. That’s what leadership means,” he said.





Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site

Published

on

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site


The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025.

Mike Blake | Reuters

Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect, building on efforts by the company and the Trump administration to make the medicine more accessible.

The announcement also comes weeks after chief rival Novo Nordisk unveiled additional discounts on the cash prices of its obesity and diabetes drugs. 

Starting Monday, cash-paying patients with a valid prescription can get the starting dose of Zepbound vials for as low as $299 per month on LillyDirect, down from a previous price of $349 per month. They can also access the next dose, 5 milligrams, for $399 per month and all other doses for $449 per month, down from $499 per month across those sizes. 

Zepbound carries a list price of roughly $1,086 per month. That price point, and spotty insurance coverage for weight loss drugs in the U.S., have been significant barriers to access for some patients. 

Eli Lilly’s announcement comes just weeks after President Donald Trump inked deals with Eli Lilly and Novo Nordisk to make their GLP-1 drugs easier for Americans to get and afford. The agreements will cut the prices the government pays for the drugs, introduce Medicare coverage of obesity drugs for the first time for certain patients and offer discounted medicines on the government’s new direct-to-consumer website launching in January, TrumpRx. 

But Eli Lilly’s deal with Trump centers around lowering the prices of a different form of Zepbound – a multi-dose pen – after it wins Food and Drug Administration approval. 

That means Eli Lilly’s Monday announcement around cutting prices on the existing single-dose vials could allow more patients to get discounted treatments more quickly. 

“We will keep working to provide more options — expanding choices for delivery devices and creating new pathways for access — so more people can get the medicines they need,” said Ilya Yuffa, president of Lilly USA and global customer capabilities, in a statement. 

Eli Lilly’s stock, which has climbed more than 36% this year, fell nearly 2% on Monday. Its meteoric rise due to the success of Zepbound and its diabetes injection Mounjaro vaulted it to becoming the first health-care company to hit a $1 trillion market value last month. Though cutting prices means lower revenue per medication sold, Eli Lilly’s sales — and shares — have continued to soar through past pricing announcements as demand balloons.

With single-dose vials, patients need to use a syringe and needle to draw up the medicine and inject it into themselves. Eli Lilly first introduced that form of Zepbound in August 2024. 

It’s unclear how many patients are currently using single-dose vials of Zepbound. But Eli Lilly previously said that direct-to-consumer sales now account for more than a third of new prescriptions of Zepbound. 

Novo Nordisk earlier this month lowered the price of its obesity drug Wegovy and diabetes treatment Ozempic for existing cash-paying patients to $349 per month from $499 per month. That excludes the highest dose of Ozempic. 

The company also launched a temporary introductory offer, which will allow new cash-paying patients to access the two lowest doses of Wegovy and Ozempic for $199 per month for the first two months of treatment. 



Source link

Continue Reading

Business

OGRA Announces LPG Price Increase for December – SUCH TV

Published

on

OGRA Announces LPG Price Increase for December – SUCH TV



The Oil and Gas Regulatory Authority (OGRA) has approved a fresh increase in the price of liquefied petroleum gas (LPG), raising the cost for both domestic consumers and commercial users.

According to the notification issued, the LPG price has been increased by Rs7.39 per kilogram, setting the new rate at Rs209 per kg for December. As a result, the price of a domestic LPG cylinder has risen by Rs87.21, bringing the new price to Rs2,466.10.

In November, the price of LPG stood at Rs201 per kg, while the domestic cylinder was priced at Rs2,378.89.

The latest price hike is expected to put additional pressure on households already grappling with rising living costs nationwide.



Source link

Continue Reading

Business

Taxable Value Of Goods Surges 15% In Sep-Oct As GST Cuts Boost Consumption

Published

on

Taxable Value Of Goods Surges 15% In Sep-Oct As GST Cuts Boost Consumption


New Delhi: The taxable value of all supplies under GST surged by a robust 15 per cent during September-October this year, compared to the same period in 2024 due to sharp increase in consumption triggered by the tax rate cuts on goods across sectors that kicked in from September 22, according to official sources.

The growth in the same two-month period last year was 8.6 per cent. “This surge in taxable value during ‘Bachat Utsav’ demonstrates strong consumption uplift, stimulated by reduced rates and improved compliance behaviour,” a senior official said.

He pointed out that the growth has especially been strong in sectors where rate rationalisation was implemented, such as FMCG, pharma goods, food products, automobiles, medical devices and textiles. In these sectors, the taxable value of supplies has seen significantly higher growth, confirming that lower GST rates translated directly into higher consumer spending.

Add Zee News as a Preferred Source


“It vindicates our strategy that reducing rates on essentials and mass-use sectors would create demand-side buoyancy — a Laffer Curve–type demand uplift,” he explained.These trends confirm that GST next-gen reforms have not disrupted revenue stability, and that consumption-side buoyancy has begun to translate into higher taxable value in key sectors.

This growth is in value terms which means that since GST rates were lower, the growth in volume terms will be even higher. It is clearly visible that while the Next Gen Reforms resulted in significant Bachat — increased consumption, industry has been very proactive in passing on the GST savings to the final consumers and ensuring that there is no supply side deficiency.

As GDP private consumption data will be released much later, GST taxable value serves as the most reliable real-time proxy for consumption, and the current numbers clearly indicate sustained demand expansion, the official added. 



Source link

Continue Reading

Trending